Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies. Its clinical product candidates include IMVT-1402, a fully human monoclonal antibody targeting FcRn in development across several...
4 insider purchases on record · latest filing 2025-09-18.
Insiders have also filed 285 sale transactions at ROIV.